PPCB Propanc Biopharma, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR에서 보기 ↗ 종가 10월 2, 2026 10-K/10-Q 9월 25, 2026
$0.51
· 52주 범위 %
· 저점 이상
· 고점까지
$0.0952주 저점
$6.7952주 고점
시가총액 (MRQ)
$2M
P/E
-0.0
EPS
$-17.62
내 배지
52주 범위
$0–$7
애널리스트 평점
·
목표 주가
·
P/E
-0.0
ROE
-190.0%
순이익률
·
배지 스트립이 비어 있습니다. 이 페이지의 아무 지표나 고정하세요.
PPCB 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$0.51
시가총액 (MRQ)
$2M
P/E
-0.0
EPS
$-17.62
ROE
-190.0%
52주 범위
$0–$7
PPCB 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
범위
막대
막대 세분성은 선택한 기간에 따라 조정됩니다. 막대의 시가/고가/저가/종가를 보려면 차트에 마우스를 올리세요.
주식 분할
| 배당락일 | 분할 | 유형 |
|---|---|---|
| 2026년 5월 18일 | 1-for-25 | 역방향 |
| 2025년 1월 29일 | 1-for-2 | 역방향 |
| 2020년 11월 19일 | 1-for-1000 | 역방향 |
| 2019년 6월 24일 | 1-for-500 | 역방향 |
| 2017년 4월 20일 | 1-for-250 | 역방향 |
10년 성과 매출, 순이익, 마진 및 EPS 추세
EPS$-17.622022-06-30 → 2026-06-30
잉여현금흐름$-6M2019-06-30 → 2026-06-30
가치 평가 및 비율
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
| 지표 | 5년 추세 | PPCB | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| P/E | -0.05년 평균 ≈-0.1 | ≈-0.1 | · | · | |
| P/B (MRQ) | 0.25년 평균 ≈-107.2 | ≈-107.2 | · | · | |
| 주가 / FCF (TTM) | -0.3 | · | · | · | |
| 주가 / 현금 흐름 (TTM) | -0.35년 평균 ≈-251.6 | ≈-251.6 | · | · | |
| Price / Tangible Book (주가 / 유형 장부 가치) | 0.2 | · | · | · |
동종 기업 중앙값은 지표별로 표준화된 기준으로 계산되며, 이 주식에 표시된 TTM/MRQ 기준과 항상 일치하지 않을 수 있습니다.
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
| 지표 | 5년 추세 | PPCB | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| ROA | -116.4%5년 평균 ≈-2563.4% | ≈-2563.4% | · | · | |
| ROE | -190.0%5년 평균 ≈-234.7% | ≈-234.7% | · | · |
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
| 지표 | 5년 추세 | PPCB | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| 유동비율 (MRQ) | 2.55년 평균 ≈0.8 | ≈0.8 | · | · | |
| Quick Ratio (당좌 비율) | 0.25년 평균 ≈0.1 | ≈0.1 | · | · |
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
이 비율 그룹에 대한 데이터가 아직 없습니다.
이 비율 그룹을 계산하기에 기본 데이터가 아직 충분하지 않습니다.
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
이 비율 그룹에 대한 데이터가 아직 없습니다.
이 비율 그룹을 계산하기에 기본 데이터가 아직 충분하지 않습니다.
가치 · ≈ 5년 평균 · 산업 중앙값 · 중앙값 대비 평가
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | · | · | · | · | · | · | · | $28.1K | $30.5K | $29.0K | · | · | |
| R&D Expense | $625.5K | $223.7K | $248.1K | $247.9K | $256.1K | $231.0K | $180.0K | $260.3K | $2M | $971.8K | $1M | $134.3K | |
| SG&A Expense | $670.6K | $109.0K | $1M | $1M | $2M | $2M | $3M | $2M | $2M | $5M | $5M | $2M | |
| Operating Expenses | $18M | $57M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $6M | $7M | $2M | |
| Operating Income | $-18M | $-57M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-6M | $-7M | $-2M | |
| Interest Expense | · | · | · | $532.8K | $568.8K | $449.5K | $2M | $1M | $3M | $3M | $4M | $1M | |
| Interest Income | · | · | · | · | $5.6K | $1 | $946 | $31 | $87 | $685 | $2.0K | $33 | |
| Other Non-op | $-6.0K | · | $-413.6K | $-1M | $-722.2K | $-327.2K | $-1M | $-3M | $-3M | $-2M | $-3M | $-2M | |
| Pretax Income | $-19M | $-59M | $-2M | $-3M | $-3M | $-2M | $-5M | $-6M | $-7M | · | · | · | |
| Income Tax | · | · | $-129.1K | $-129.8K | $-55.0K | $-113.4K | $-134.7K | $-115.4K | $-179.3K | $-305.7K | $-72.5K | $-77.5K | |
| Net Income | $-19M | $-59M | $-2M | $-3M | $-3M | $-2M | $-5M | $-6M | $-7M | $-8M | $-9M | $-3M | |
| EPS (Basic) | $-17.62 | $-371.22 | $-1420.53 | $-1.80 | $-49.23 | $-0.80 | · | · | · | · | · | · | |
| EPS (Diluted) | $-17.62 | $-371.22 | $-1420.53 | $-1.80 | $-49.23 | · | · | · | · | · | · | · | |
| Shares (Basic) | 1,123,709 | 158,727 | 1,417 | 1,738,802 | 68,219 | 3,032,612 | · | · | · | · | · | · | |
| Shares (Diluted) | 1,123,709 | 158,727 | 1,417 | 1,738,802 | 68,219 | · | · | · | · | · | · | · | |
| EBITDA | $-18M | $-57M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-6M | $-7M | $-2M |
대차대조표
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $832.0K | $12.1K | $21.1K | $10.0K | $4.1K | $2.3K | $67.0K | $2.4K | $19.9K | $69.0K | $121.1K | $107.6K | |
| Prepaid Expense | $8M | $8M | · | $6.1K | $8.6K | · | · | $83.3K | $34.7K | $4.8K | $210.1K | $502.6K | |
| Other Current Assets | $34.9K | $1.4K | $1.4K | · | · | · | · | · | · | · | · | · | |
| Current Assets | $9M | $8M | $25.4K | $19.0K | $15.0K | $6.6K | $69.0K | $91.1K | $60.9K | $82.0K | $362.8K | $621.9K | |
| PP&E (Net) | $3.9K | · | · | $302 | $2.0K | $4.3K | $5.7K | $8.4K | $8.3K | $10.8K | $12.5K | $3.5K | |
| PP&E (Gross) | $31.3K | $25.1K | $25.5K | $25.4K | $28.6K | $28.6K | $26.3K | $26.7K | $25.2K | $26.2K | $25.3K | $15.7K | |
| Accum. Depreciation | $27.4K | $25.1K | $25.5K | $25.1K | $26.6K | $24.4K | $20.6K | $18.3K | $17.0K | $15.4K | $12.7K | $12.2K | |
| Total Assets | $13M | $20M | $72.4K | $60.3K | $81.7K | $13.1K | $98.5K | $101.7K | $71.4K | $95.1K | $379.1K | $627.1K | |
| Accounts Payable | $1M | $1M | $1M | $966.7K | $943.0K | $1M | $842.2K | $917.3K | $1M | $483.5K | $370.1K | $236.5K | |
| Short-term Debt | · | $543.3K | $204.7K | · | · | · | · | · | · | · | $2.2K | $27.6K | |
| Current Liabilities | $3M | $6M | $4M | $3M | $3M | $3M | $4M | $4M | $7M | $6M | $3M | $4M | |
| Capital Leases | $23.8K | $41.7K | · | · | $42.3K | · | · | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $58.0K | $109.6K | |
| Total Liabilities | $3M | $6M | $4M | $3M | $3M | $3M | $4M | $4M | · | · | · | · | |
| Long-term Debt | · | $537.9K | $399.3K | $390.5K | $926.4K | $624.6K | $2M | $2M | $5M | $3M | $1M | · | |
| Total Debt | · | $543.3K | $204.7K | · | · | · | · | · | · | · | $2.2K | $27.6K | |
| Common Stock | $3.3K | $464 | $8 | $6.0K | $220 | $14.1K | $258 | $968 | $93 | $4.6K | $2.9K | $347.4K | |
| Paid-in Capital | $153M | $138M | $62M | $60M | $57M | $54M | $51M | $46M | $38M | $33M | $28M | $17M | |
| Retained Earnings | $-144M | $-126M | $-67M | $-65M | $-62M | $-58M | $-56M | $-51M | $-45M | $-38M | $-30M | $-21M | |
| Treasury Stock | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | · | · | |
| AOCI | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $357.9K | $-141.7K | $131.3K | $101.0K | |
| Stockholders' Equity | $9M | $14M | $-4M | $-3M | $-3M | $-3M | $-4M | $-4M | $-7M | $-5M | $-3M | $-3M | |
| Liabilities + Equity | $13M | $20M | $72.4K | $60.3K | $81.7K | $13.1K | $98.5K | $101.7K | $71.4K | $95.1K | $379.1K | $627.1K | |
| Shares Outstanding | 3,310,827 | 464,471 | 7,980 | 6,031,250 | 220,351 | 14,055,393 | 258,120 | 967,993 | 92,810 | 4,553,806 | 2,914,465 | 347,442,013 |
현금 흐름
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $8M | $5M | · | $2.4K | $72.5K | $82.9K | $300.4K | · | $516.1K | $2M | $2M | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Operating Cash Flow | $-6M | $-405.2K | $-935.1K | $-1M | $-1M | $-1M | $-2M | $-2M | $-2M | $-2M | $-5M | $-1M | |
| CapEx | $4.9K | · | · | · | · | · | · | $2.9K | · | · | $9.9K | $3.9K | |
| Investing Cash Flow | $-4.9K | · | · | · | · | · | · | $-2.9K | · | · | · | $-5.6K | |
| Stock Issued | $3M | · | $23.1K | $24.7K | $99.3K | · | $450.0K | $1M | · | · | $0 | $29.0K | |
| Net Stock Activity | $3M | · | $23.1K | $24.7K | $99.3K | · | $450.0K | $1M | · | · | $0 | $29.0K | |
| Financing Cash Flow | $6M | $490.8K | $941.9K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | · | · | |
| Net Change in Cash | $819.9K | $-9.0K | $11.0K | $6.0K | $1.8K | $-64.8K | $64.6K | $-17.5K | $-49.1K | · | · | · | |
| Free Cash Flow | $-6M | · | · | · | · | · | · | $-2M | · | · | $-5M | $-1M | |
| Levered FCF | · | · | · | · | · | · | · | $-3M | · | · | · | · |
수익성
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -116.4% | -598.1% | -2744.0% | -3747.8% | -5610.6% | -4332.1% | -4736.7% | -6655.6% | -8457.7% | -3318.1% | -1870.5% | -921.4% | |
| ROE | -190.0% | -1209.0% | 48.7% | 87.8% | 89.0% | 79.6% | 111.7% | 149.3% | 104.1% | 196.5% | 335.0% | 153.0% | |
| ROIC | · | · | 40.1% | 54.3% | 64.5% | 55.9% | · | 59.6% | · | · | · | · |
유동성 및 지급능력
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 1.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | |
| Quick Ratio | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt / Equity | · | 0.0 | -0.1 | · | · | · | · | · | · | · | -0.0 | -0.0 | |
| Interest Coverage | · | · | · | -3.3 | -3.5 | -4.0 | -2.0 | -2.0 | -1.4 | -1.8 | -1.5 | -1.3 |
주당
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.84 | $1.20 | $-0.01 | $-0.52 | $-0.01 | $-0.22 | $-0.01 | $-4.44 | $-0.15 | $-1.19 | $-0.00 | $-0.01 | |
| Cash Flow / Share | $-5.06 | $-0.10 | $-0.01 | $-0.64 | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.25 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.02 | $0.00 | $0.00 | |
| EPS (TTM) | $-17.62 | $-14.85 | $-1420.53 | $-1.80 | $-49.23 | · | · | · | · | · | · | · |
가치 평가 (TTM)
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-19M | $-59M | $-2M | $-3M | $-3M | $-2M | $-5M | $-6M | $-7M | $-8M | $-9M | $-3M | |
| Market Cap | $5M | $48M | $1M | $2M | $1.63B | $1.45B | $2.01T | $11.62T | $2552.27T | · | · | · | |
| Enterprise Value | · | $49M | $1M | · | · | · | · | · | · | · | · | · | |
| P/E | -0.1 | -0.3 | 0.0 | -0.1 | -0.2 | · | · | · | · | · | · | · | |
| P/B | 0.5 | 3.5 | -0.3 | -0.5 | -539.3 | -473.8 | -552898.5 | -2700599.5 | -378006844.7 | · | · | · | |
| P / Tangible Book | 0.5 | 3.5 | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | -0.9 | -118.9 | -1.3 | -1.5 | -1135.3 | -1269.0 | -1088533.0 | -5638692.9 | -1172033079.3 | · | · | · | |
| P / FCF | · | · | · | · | · | · | · | -5630837.2 | · | · | · | · | |
| EV / EBITDA | · | -0.9 | -0.9 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -1174.7% | -357.8% | -54635769.2% | -666.7% | -665.3% | · | · | · | · | · | · | · |
손익계산서
| 지표 | 추세 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $375.7K | $169.7K | $20.0K | $60.2K | $53.5K | $54.1K | $54.4K | $61.7K | $52.4K | $65.4K | $114.0K | $16.2K | $5.7K | $66.0K | $74.9K | $101.3K | |
| SG&A Expense | $-14M | $6M | $4M | $5M | $-53M | $53M | $153.6K | $220.8K | $192.9K | $348.8K | $318.2K | $393.8K | $197.3K | $311.8K | $525.6K | $465.1K | |
| Operating Expenses | $3M | $6M | $4M | $5M | $4M | $53M | $213.4K | $290.8K | $259.9K | $420.9K | $438.1K | $417.2K | $209.6K | $386.2K | $608.0K | $572.8K | |
| Operating Income | $-3M | $-6M | $-4M | $-5M | $-4M | $-53M | $-213.4K | $-290.8K | $-259.9K | $-420.9K | $-438.1K | $-417.2K | $-209.6K | $-386.2K | $-608.0K | $-572.8K | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $133.1K | $264.5K | $178.2K | · | $157.2K | $98.6K | $162.8K | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2 | |
| Other Non-op | $-448.2K | $43.0K | $563.3K | $-164.2K | $-426.2K | · | $-216.8K | $-63.5K | $-98.9K | $-106.1K | $-274.9K | $66.4K | $-537.2K | $-425.3K | $-6.7K | $-44.5K | |
| Pretax Income | $-5M | $-6M | $-3M | $-5M | $-4M | $-54M | $-430.2K | $-354.3K | $-358.8K | $-527.0K | $-713.0K | $-350.9K | $-746.8K | $-811.5K | $-614.7K | $-617.3K | |
| Income Tax | · | · | · | · | · | · | · | · | $-237 | $-275 | $-128.6K | · | $1.2K | $-1.7K | $-129.3K | · | |
| Net Income | $-5M | $-6M | $-3M | $-5M | $-4M | $-54M | $-430.2K | $-354.3K | $-358.6K | $-526.7K | $-584.4K | $-350.9K | $-748.0K | $-809.8K | $-485.4K | $-617.3K | |
| EPS (Basic) | $-16.65 | $-0.28 | $-0.30 | $-0.39 | $-290.52 | $-12.50 | $-32.23 | $-35.97 | $684.85 | $-545.79 | $-1559.55 | $-0.04 | $1.28 | $-0.42 | $-0.53 | $-2.13 | |
| EPS (Diluted) | $-16.65 | $-0.28 | $-0.30 | $-0.39 | $-290.52 | $-12.50 | $-32.23 | $-35.97 | $684.85 | $-545.79 | $-1559.55 | $-0.04 | $1.28 | $-0.42 | $-0.53 | $-2.13 | |
| Shares (Basic) | · | 22,427,486 | 13,360,358 | 12,331,526 | · | 4,325,994 | 13,347 | 9,849 | · | 994 | 397 | 10,989,681 | · | 1,924,074 | 960,471 | 473,589 | |
| Shares (Diluted) | · | 22,427,486 | 13,360,358 | 12,331,526 | · | 4,325,994 | 13,347 | 9,849 | · | 994 | 397 | 10,989,681 | · | 1,924,074 | 960,471 | 473,589 | |
| EBITDA | · | $-6M | $-4M | $-5M | · | $-53M | $-213.4K | $-290.8K | · | $-420.9K | $-438.1K | $-417.2K | · | $-386.2K | $-608.0K | $-572.8K |
대차대조표
| 지표 | 추세 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $832.0K | $443.7K | $561.2K | $602.7K | $12.1K | $50.8K | $14.6K | $9.3K | $21.1K | $6.2K | $71.7K | $6.6K | $10.0K | $93.2K | $24.5K | $19.4K | |
| Prepaid Expense | $8M | $8M | $7M | $8M | $8M | $10M | $1.4K | $9.0K | · | $1.4K | $12.1K | $20.4K | $6.1K | · | $25.2K | $15.8K | |
| Other Current Assets | $34.9K | $35.1K | $1.4K | $8.8K | $1.4K | $1.3K | · | · | $1.4K | · | · | · | · | · | · | · | |
| Current Assets | $9M | $8M | $8M | $9M | $8M | $10M | $18.0K | $21.5K | $25.4K | $12.9K | $210.8K | $145.8K | $19.0K | $96.6K | $54.2K | $37.9K | |
| PP&E (Net) | $3.9K | $4.2K | $4.4K | $2.4K | · | · | · | · | · | · | $50 | $160 | $302 | $634 | $1.1K | $1.4K | |
| PP&E (Gross) | $31.3K | $31.2K | $30.2K | $27.8K | $25.1K | $23.8K | $23.6K | $26.5K | $25.5K | $24.9K | $26.0K | $24.5K | $25.4K | $25.6K | $26.0K | $28.6K | |
| Accum. Depreciation | $27.4K | $27.0K | $25.8K | $25.4K | $25.1K | $23.8K | $23.6K | $26.5K | $25.5K | $24.9K | $26.0K | $24.4K | $25.1K | $24.9K | $24.9K | $27.2K | |
| Total Assets | $13M | $14M | $15M | $18M | $20M | $23M | $78.5K | $63.6K | $72.4K | $37.3K | $241.9K | $180.4K | $60.3K | $143.7K | $108.0K | $94.3K | |
| Accounts Payable | $1M | $973.7K | $957.5K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $966.7K | $918.2K | $914.5K | $899.2K | |
| Short-term Debt | · | · | · | · | $543.3K | $281.5K | $168.2K | $213.1K | $204.7K | $132.0K | $132.0K | $126.0K | · | · | $72.4K | · | |
| Current Liabilities | $3M | $3M | $4M | $4M | $6M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Capital Leases | $23.8K | $30.3K | $35.2K | $42.1K | $41.7K | · | · | · | · | · | · | · | · | $24.9K | $30.9K | $39.4K | |
| Total Liabilities | $3M | $4M | $4M | $4M | $6M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Long-term Debt | · | $55.0K | $55.0K | $107.0K | $537.9K | $438.6K | $409.8K | $381.8K | $399.3K | $583.0K | $687.6K | $397.4K | $390.5K | $519.7K | · | $913.6K | |
| Total Debt | · | · | · | · | · | $281.5K | $168.2K | $213.1K | · | $132.0K | $132.0K | $126.0K | · | · | $72.4K | · | |
| Common Stock | $3.3K | $21.9K | $13.4K | $12.8K | $464 | $11.6K | $14 | $688.0K | $8 | $109.7K | $36.2K | $14.8K | $6.0K | $3M | $1M | $677.2K | |
| Paid-in Capital | $153M | $149M | $144M | $144M | $138M | $138M | $62M | $61M | $62M | $61M | $61M | $61M | $60M | $57M | $58M | $58M | |
| Retained Earnings | $-144M | $-141M | $-134M | $-130M | $-126M | $-122M | $-67M | $-67M | $-67M | $-66M | $-66M | $-65M | $-65M | $-64M | $-63M | $-63M | |
| Treasury Stock | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | $46.5K | |
| AOCI | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Stockholders' Equity | $9M | $10M | $10M | $14M | $14M | $18M | $-4M | $-4M | $-4M | $-4M | $-4M | $-3M | $-3M | $-3M | $-3M | $-3M | |
| Liabilities + Equity | $13M | $14M | $15M | $18M | $20M | $23M | $78.5K | $63.6K | $72.4K | $37.3K | $241.9K | $180.4K | $60.3K | $143.7K | $108.0K | $94.3K | |
| Shares Outstanding | 3,310,827 | 21,859,281 | 13,449,688 | 12,806,748 | 464,471 | 11,611,782 | 14,508 | 688,022,017 | 7,980 | 109,706,411 | 36,169,023 | 14,833,210 | 6,031,250 | 2,621,297,786 | 1,245,699,501 | 677,177,717 |
현금 흐름
| 지표 | 추세 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $2M | $2M | $3M | $3M | · | · | · | · | · | · | · | $0 | $0 | $0 | $2.4K | |
| Operating Cash Flow | $-2M | $-1M | $-999.1K | $-2M | $-92.2K | $-136.2K | $18.7K | $-235.5K | $-260.0K | $-102.8K | $-238.9K | $-333.5K | $-178.0K | $-192.7K | $-225.2K | $-509.3K | |
| CapEx | $21 | $154 | $2.3K | $2.5K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Investing Cash Flow | $-21 | $-154 | $-2.3K | $-2.5K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $0 | $0 | $0 | $3M | · | · | · | · | $12.0K | · | · | · | $0 | $0 | $0 | $24.7K | |
| Net Stock Activity | · | · | · | $3M | · | · | · | · | · | · | · | · | · | · | · | $24.7K | |
| Financing Cash Flow | $2M | $981.6K | $965.1K | $3M | $72.8K | $187.5K | $54.8K | $215.7K | $251.0K | $66.6K | $273.9K | $350.3K | $100.0K | $269.5K | $250.0K | $494.2K | |
| Net Change in Cash | $388.3K | $-117.5K | $-41.5K | $590.6K | $-38.7K | $36.1K | $5.4K | $-11.8K | $14.9K | $-65.4K | $65.0K | $-3.4K | $-83.2K | $68.8K | $5.1K | $15.3K | |
| Free Cash Flow | · | · | · | $-2M | · | · | · | · | · | · | · | · | · | · | · | · |
수익성
| 지표 | 추세 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | -34.5% | -40.7% | -53.6% | · | -479.2% | -268.5% | -290.4% | · | -581.7% | -334.0% | -255.5% | · | -517.1% | -444.9% | -789.3% | |
| ROE | · | -45.6% | -98.2% | -94.4% | · | -751.3% | 11.1% | 10.0% | · | 15.9% | 18.0% | 12.2% | · | 27.5% | 16.6% | 24.3% | |
| ROIC | · | · | · | · | · | · | · | · | · | 11.8% | 10.5% | · | · | 13.1% | 16.9% | · |
유동성 및 지급능력
| 지표 | 추세 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.4 | 2.1 | 2.5 | · | 2.2 | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | |
| Quick Ratio | · | 0.1 | 0.2 | 0.2 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | |
| Debt / Equity | · | · | · | · | · | 0.0 | -0.0 | -0.1 | · | -0.0 | -0.0 | -0.0 | · | · | -0.0 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -3.2 | -1.7 | -2.3 | · | -2.5 | -6.2 | -3.5 |
주당
| 지표 | 추세 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $0.45 | $0.78 | $1.12 | · | $1.56 | $-286.65 | $-0.01 | · | $-0.03 | $-0.10 | $-0.20 | · | $-0.00 | $-0.00 | $-0.00 | |
| Cash Flow / Share | · | · | · | $-0.16 | · | · | · | $-0.00 | · | · | · | $-0.03 | · | · | · | · | |
| Cash / Share | · | $0.02 | $0.04 | $0.05 | · | $0.00 | $1.01 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | |
| EPS (TTM) | · | $-291.49 | $-303.71 | $-335.64 | · | $604.15 | $70.86 | $-1456.46 | · | $-2104.10 | $-1558.73 | $0.29 | · | · | · | · |
가치 평가 (TTM)
| 지표 | 추세 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | · | $-18M | $-66M | $-63M | · | $-55M | $-2M | $-2M | · | $-2M | $-2M | $-2M | · | $-3M | $-2M | $-3M | |
| Market Cap | · | $2M | $7M | $22M | · | $64M | $6 | $412.8K | · | $702.1K | $868.1K | $723.9K | · | $2.62B | $1.49B | $1.63B | |
| Enterprise Value | · | · | · | · | · | $64M | $153.6K | $616.7K | · | $827.9K | $928.4K | $843.2K | · | · | $1.49B | · | |
| P/E | · | -0.0 | -0.0 | -0.0 | · | 0.0 | 0.0 | 0.0 | · | -0.0 | -0.0 | 10.8 | · | · | · | · | |
| P/B | · | 0.2 | 0.7 | 1.5 | · | 3.5 | 0.0 | -0.1 | · | -0.2 | -0.2 | -0.2 | · | -891.2 | -512.7 | -587.2 | |
| P / Tangible Book | · | 0.2 | 0.7 | 1.5 | · | 3.5 | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | · | · | -11.2 | · | · | · | -1.8 | · | · | · | -2.2 | · | · | · | -3191.0 | |
| Earnings Yield | · | -274990.6% | -56599.0% | -19743.5% | · | 10984.5% | 276796.9% | -3792864.6% | · | -513696.3% | -101479.8% | 9.3% | · | · | · | · |
최신 기간은 왼쪽에 · null 값은 ·로 표시
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
| 지표 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| 순이익 | $-19M | $-59M | $-2M | $-3M | $-3M |
| 희석 EPS | $-17.62 | $-371.22 | $-1420.53 | $-1.80 | $-49.23 |
| 지표 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | · | 0.0 | -0.1 | · | · |
| 유동비율 | 2.5 | 1.5 | 0.0 | 0.0 | 0.0 |
| 당좌 비율 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 |
| 지표 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-6M | · | · | · | · |
기관 투자자 (13F)
기관 활동 — Q1 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 4 (+1 이전 분기 대비) | 3 (+2 이전 분기 대비) | 1 (+1 이전 분기 대비) | 1 (0 이전 분기 대비) | +334K |
Q4 2025 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
행동주의자 및 5% 이상 소유자 1 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Putney Consultants Ltd. | 2015년 1월 2일 | · | 최초 제출 | 수동적 투자 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
회사 내부자 3 명의 내부자 · 2 임원 · 3 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| James Andrew Nathanielsz | CEO/CFO | 2021년 8월 17일 A | 2,800,000 | 0 | 0 | $0 |
| Julian Norman Kenyon | Chief Scientific Officer | 2021년 8월 17일 A | 3,420,005 | 0 | 0 | $0 |
| Josef Zelinger | 이사 | 2023년 7월 5일 A | · | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
회계연도 기준, 각 회사의 마지막 회계연도 말 종가 기준 가격입니다.
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| PPCB | $5M | -0.1 | · | · | -190.0% | · |
| NEUP | $24M | -1.4 | -92.5% | -1145.7% | -49.5% | · |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요. 상단의 전체 기본 정보에서 원하는 행 옆의 +를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
출처: SEC 10-K 제출 9월 25, 2026